ANA negative (Ro) lupus erythematosus with multiple major organ involvement: A case report

Asian Pacific Journal of Allergy and Immunology

Volumn 20, Issue 4, 2002, Pages 279-282

  Maraina, Che Hussin Che ^a   Kamaliah, Mohd Daud ^a   Ishak, Mat ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINUCLEAR ANTIBODY; METHYLPREDNISOLONE; PHENYTOIN; PREDNISOLONE; STEROID;

ADULT; ALOPECIA; ANEMIA; ARTHRALGIA; ARTICLE; BRAIN DISEASE; CASE REPORT; CHINESE; CLINICAL FEATURE; CONVULSION; DISEASE ASSOCIATION; FEMALE; FEVER; FOLLOW UP; HEMATOLOGIC DISEASE; HEMATURIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMUNOASSAY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUTH ULCER; MULTIPLE ORGAN FAILURE; MUSCULOSKELETAL DISEASE; PROTEINURIA; RASH; REMISSION; THROMBOCYTOPENIA; VASCULAR LESION;

ADULT; ALOPECIA; ANTIBODIES, ANTINUCLEAR; ARTHRALGIA; AUTOANTIBODIES; EXANTHEMA; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; ORAL ULCER;

EID: 0037961682     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Manolios N, Schrieber L. Systemic lupus erythematosus. In: Bradley J, McCluskey J, eds, Clinical Immunology, Philadelphia, Oxford Medical Publications, 1997: 329-45.
2. Hahn BH. Systemic Lupus Erythematosus. In: Harrison's Principles of Internal Medicine, 14th Edition. 1998: pp. 1874-80.
3. Tan EM, Cohen A, Fries J, et al. Special article: The 1982 revised criteria for the classification of systemic lupus erythematosus. Clin Immunol Immunopathol 1982; 25: 1271-7.
4. Fronex Z, Timmerman LA, Alper CA, et al. Major histocompatibility complex associations with systemic lupus erythematosus. Am J Med 1988; 85 (6A): 42-4.
5. Locham KK, Jaswir S, Rajinder G, Manjit S, Chanchal J. Case report: ANA negative lupus erythematosus. Indian Pediatrics 2000; 37: 540-2.
6. Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-151.
7. Noz KC. ANA-negative systemic lupus erythematosus. Br J Dermatol 1993; 129: 345-6.
8. 1 mice. Eur J Immunol 1971; 1: 396-8.
9. Ritchie RF. The clinical significance of titered anti-nuclear antibodies. Arthritis Rheum 1967; 10: 544-52.
10. Appel GB, Williams GS, Meltzer JI. Renal vein thrombosis nephritic syndrome and systemic lupus erythematosus. Ann Intern Med 1976; 85: 310-7.
11. Fessel WJ. Epidemiology of systemic lupus erythematosus. Rheum Dis Clin North America 1988; 14(1): 15-23.
12. Cohen AS, Reynolds WE, Franklin EC. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971; 21: 6435.
13. Alexander EL, Ranzenbach MR, Kumar AJ, Kozachuk WE, Rosenbaum AE, Patronas N, Harley JB, Reichlin M. Anti-Ro (SS-A) autoantibodies in central nervous system disease associated owith Sjögren's syndrome. (CNS-SS): Clinical, neuroimaging and angiographic correlates. Neurology 1994; 44(5): 899-908.
14. Leu LY, Lan JL. The influence on pregnancy of anti-SSA/Ro antibodies in systemic upus erythematosus. Zhonhua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1992; 25(1): 12-20.
15. Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 1994; 20 (1): 87-118.
16. McCauliffe DP. Neonatal lupus erythematosus: A transplacentally acquired autoimmune disorder. Semin Dermatol 1995; 14(1): 47-53.
17. Simmons-O'Brien E, Chen S, Watson R, Antoni C. Petri M, Hochberg M, Stevens MB, Provost TT. One hundred anti-Ro antibody positive patients: A 10-year follow-up. Medicine (Baltimore) 1995; 74(3): 109-30.